Vis enkel innførsel

dc.contributor.authorEldholm, Rannveig Sakshaug
dc.contributor.authorPersson, Karin Ester Torun
dc.contributor.authorBarca, Maria Lage
dc.contributor.authorKnapskog, Anne Brita
dc.contributor.authorCavallin, Lena
dc.contributor.authorEngedal, Knut
dc.contributor.authorSelbæk, Geir
dc.contributor.authorSkovlund, Eva
dc.contributor.authorSaltvedt, Ingvild
dc.coverage.spatialNorgeen_US
dc.date.accessioned2020-03-06T15:01:40Z
dc.date.available2020-03-06T15:01:40Z
dc.date.issued2018
dc.identifier.citationEldholm et al. BMC Geriatrics (2018) 18:120 https://doi.org/10.1186/s12877-018-0813-4en_US
dc.identifier.issn1471-2318
dc.identifier.urihttps://hdl.handle.net/11250/2645875
dc.description.abstractAbstract BACKGROUND: Vascular risk factors increase the risk of Alzheimer's disease (AD), but there is limited evidence on whether comorbid vascular conditions and risk factors have an impact on disease progression. The aim of this study was to examine the association between vascular disease and vascular risk factors and progression of AD. METHODS: In a longitudinal observational study in three Norwegian memory clinics, 282 AD patients (mean age 73.3 years, 54% female) were followed for mean 24 (16-37) months. Vascular risk factors and vascular diseases were registered at baseline, and the vascular burden was estimated by the Framingham Stroke Risk Profile (FSRP). Cerebral medical resonance images (MRIs) were assessed for white matter hyperintensities (WMH), lacunar and cortical infarcts. The associations between vascular comorbidity and progression of dementia as measured by annual change in Clinical Dementia Rating Sum of Boxes (CDR-SB) scores were analysed by multiple regression analyses, adjusted for age and sex. RESULTS: Hypertension occurred in 83%, hypercholesterolemia in 53%, diabetes in 9%, 41% were overweight, and 10% were smokers. One third had a history of vascular disease; 16% had heart disease and 15% had experienced a cerebrovascular event. MRI showed lacunar infarcts in 16%, WMH with Fazekas score 2 in 26%, and Fazekas score 3 in 33%. Neither the vascular risk factors and diseases, the FSRP score, nor cerebrovascular disease was associated with disease progression in AD. CONCLUSIONS: Although vascular risk factors and vascular diseases were prevalent, no impact on the progression of AD after 2 years was shown.en_US
dc.description.sponsorshipThe work by Rannveig S. Eldholm and Maria L. Barca was funded from the Norwegian ExtraFoundation for Health and Rehabilitation through the Norwegian Health Association. Rannveig S. Eldholm also received funding from the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (NTNU). Karin Persson’s work was funded by the Southern and Eastern Norway Regional Health Authority.en_US
dc.language.isoengen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectAlzheimer’s disease;en_US
dc.subjectCardiovascular disease;en_US
dc.subjectCardiovascular risk;en_US
dc.subjectCognitive decline;en_US
dc.subjectDementia;en_US
dc.subjectMild cognitive impairment;en_US
dc.subjectPrognosis;en_US
dc.subjectProgression;en_US
dc.subjectVascular risk factorsen_US
dc.titleAssociation between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinicsen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en_US
dc.source.pagenumber8en_US
dc.source.volume18en_US
dc.source.journalBMC Geriatricsen_US
dc.source.issue120en_US
dc.identifier.doi10.1186/s12877-018-0813-4
dc.identifier.cristin1586104


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal